Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma.
Peng K, Zhang X, Li Z, Wang Y, Sun HW, Zhao W, Pan J, Zhang XY, Wu X, Yu X, Wu C, Weng Y, Lin X, Liu D, Zhan M, Xu J, Zheng L, Zhang Y, Lu L.
Peng K, et al. Among authors: liu d.
Front Immunol. 2024 Dec 2;15:1493735. doi: 10.3389/fimmu.2024.1493735. eCollection 2024.
Front Immunol. 2024.
PMID: 39687612
Free PMC article.